UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000051237
Receipt number R000056964
Scientific Title Comparison of the ability of Artifical intelligence-based computer-aided detection (CAD) systems and endoscopists to detect colorectal neoplastic lesions.
Date of disclosure of the study information 2023/06/02
Last modified on 2023/12/02 09:15:50

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Comparison of the ability of artifical intelligence-based computer-aided detection (CAD) systems and endoscopists to detect colorectal neoplastic lesions.

Acronym

Comparison of the ability of CAD systems and endoscopists to detect colorectal neoplastic lesions.

Scientific Title

Comparison of the ability of Artifical intelligence-based computer-aided detection (CAD) systems and endoscopists to detect colorectal neoplastic lesions.

Scientific Title:Acronym

Comparison of the ability of CAD systems and endoscopists to detect colorectal neoplastic lesions.

Region

Japan


Condition

Condition

colorectal polyp

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To identify the superiority of CAD and endoscopists' ability to detect colorectal neoplastic lesions.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Superiority of time taken by the endoscopist to detect colorectal neoplastic polyps versus by the CAD to detect colorectal neoplastic polyps (number of wins/losses)

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

All cases of colonoscopy performed from June 1st 2022 to July 31th 2022 by the study coordinator at Tokyo Women's Medical University hospital in which two types of videos were recorded simultaneously, one using the CAD function and the other not using it.

Endoscopists who view the videos will be selected from endoscopists who work in the Institute of Gastroenterology, or the Department of Digestive Endoscopy at Tokyo Women's Medical University Hospital and who perform colonoscopies on a daily basis. 3 experts who have performed more than 5000 colonoscopies and 3 beginners who have performed less than 500 colonoscopies will be selected.

Key exclusion criteria

Cases with poor preparation
Cases in which CAD indicated more than 5 colorectal polyps of 10 mm or less
Cases in which endoscopic procedures were performed including biopsy
Cases in which no neoplastic lesions were detected
Inflammatory bowel disease and polyposis
Cases with an examination time of 20 minutes or longer

Target sample size

46


Research contact person

Name of lead principal investigator

1st name Yoshitsugu
Middle name
Last name Misumi

Organization

Tokyo Women's Medical University Hospital

Division name

Department of Digestive Endoscopy

Zip code

162-8666

Address

8-1, Kawada-cho, Shinjuku-ku, Tokyo, Japan.

TEL

+81333538111

Email

yoshikft34@gmail.com


Public contact

Name of contact person

1st name Yoshitsugu
Middle name
Last name Misumi

Organization

Tokyo Women's Medical University Hospital

Division name

Department of Digestive Endoscopy

Zip code

162-8666

Address

8-1, Kawada-cho, Shinjuku-ku, Tokyo, Japan.

TEL

+81333538111

Homepage URL


Email

yoshikft34@gmail.com


Sponsor or person

Institute

Tokyo Women's Medical University Hospital

Institute

Department

Personal name



Funding Source

Organization

None.

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Tokyo Women's Medical University Hospital

Address

8-1, Kawada-cho, Shinjuku-ku, Tokyo, Japan.

Tel

+81333538111

Email

yoshikft34@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 06 Month 02 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

47

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2023 Year 05 Month 31 Day

Date of IRB

2023 Year 05 Month 31 Day

Anticipated trial start date

2023 Year 06 Month 01 Day

Last follow-up date

2023 Year 06 Month 10 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Study design
This study involves a single center, Tokyo Women's Medical University Hospital. Endoscopy videos are used to evaluate whether CAD EYE, an AI equipped colonoscope CAD system, is superior to endoscopists in its ability to detect colorectal neoplastic lesions, and to compare the times needed by CAD EYE and the endoscopists to detect tumors. This study approved by the ethics committee of Tokyo Women's Medical University. Informed consent was obtained from all patients for using the videos. Patients are free to withdraw consent at any time. In addition to the study coordinator, Endoscopist A, a total of six people participated in this study, three experts (>5000 colonoscopies) and three beginners (<500 colonoscopies).

Study population
The study will use colonoscopies performed by Endoscopist A at Tokyo Women's Medical University Hospital from June 1 to July 30, 2022, using a high- definition colonoscope and a high-definition monitor. We do not examine the symptoms, purpose of examination, age, or sex of any of the patients. The inclusion criteria are the presence of at least one neoplastic lesion (adenoma or adenocarcinoma) measuring<10mm. For the final determination of whether the lesion is neoplastic, the gold standard is CAD EYE's CADx diagnosis. Patients with poor pretreatment, with >5 neoplastic lesions, with inflammatory bowel disease, with polyposis, who underwent endoscopic procedures that include biopsies, and whose examination took>20 min will be excluded.


Management information

Registered date

2023 Year 06 Month 02 Day

Last modified on

2023 Year 12 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000056964


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name